# Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma

> **NCT00596219** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- SQUAMOUS CELL CARCINOMA

## Interventions

- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT00596219
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2006-10
- **Final completion:** 2010-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596219, "Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00596219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*